ENDPQ — Endo International Balance Sheet
0.000.00%
- $0.14m
- $7.37bn
- $2.01bn
- 26
- 92
- 15
- 41
Annual balance sheet for Endo International, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1,455 | 1,213 | 1,507 | 1,019 | 778 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 516 | 578 | 602 | 503 | 397 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,586 | 2,413 | 2,715 | 2,077 | 1,669 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 557 | 496 | 432 | 466 | 499 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 9,390 | 9,265 | 8,767 | 5,758 | 5,137 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,460 | 1,254 | 1,630 | 690 | 539 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 10,256 | 9,913 | 10,011 | 9,920 | 11,735 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -867 | -648 | -1,244 | -4,162 | -6,598 |
| Total Liabilities & Shareholders' Equity | 9,390 | 9,265 | 8,767 | 5,758 | 5,137 |
| Total Common Shares Outstanding |